Kongkam Pradermchai, Linlawan Sittikorn, Aniwan Satimai, Lakananurak Narisorn, Khemnark Suparat, Sahakitrungruang Chucheep, Pattanaarun Jirawat, Khomvilai Supakij, Wisedopas Naruemon, Ridtitid Wiriyaporn, Bhutani Manoop S, Kullavanijaya Pinit, Rerknimitr Rungsun
Pradermchai Kongkam, Sittikorn Linlawan, Satimai Aniwan, Narisorn Lakananurak, Suparat Khemnark, Wiriyaporn Ridtitid, Pinit Kullavanijaya, Rungsun Rerknimitr, Gastrointestinal Endoscopy Excellent Center, Department of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok 10330, Thailand.
World J Gastroenterol. 2014 Mar 14;20(10):2681-7. doi: 10.3748/wjg.v20.i10.2681.
To evaluate feasibility of the novel forward-viewing radial-array echoendoscope for staging of colon cancer beyond rectum as the first series.
A retrospective study with prospectively entered database. From March 2012 to February 2013, a total of 21 patients (11 men) (mean age 64.2 years) with colon cancer beyond the rectum were recruited. The novel forward-viewing radial-array echoendoscope was used for ultrasonographic staging of colon cancer beyond rectum. Ultrasonographic T and N staging were recorded when surgical pathology was used as a gold standard.
The mean time to reach the lesion and the mean time to complete the procedure were 3.5 and 7.1 min, respectively. The echoendoscope passed through the lesions in 13 patients (61.9%) and reached the cecum in 10 of 13 patients (76.9%). No adverse events were found. The lesions were located in the cecum (n = 2), ascending colon (n = 1), transverse colon (n = 2), descending colon (n = 2), and sigmoid colon (n = 14). The accuracy rate for T1 (n = 3), T2 (n = 4), T3 (n = 13) and T4 (n = 1) were 100%, 60.0%, 84.6% and 100%, respectively. The overall accuracy rates for the T and N staging of colon cancer were 81.0% and 52.4%, respectively. The accuracy rates among traversable lesions (n = 13) and obstructive lesions (n = 8) were 61.5% and 100%, respectively. Endoscopic ultrasound and computed tomography had overall accuracy rates of 81.0% and 68.4%, respectively.
The echoendoscope is a feasible staging tool for colon cancer beyond rectum. However, accuracy of the echoendoscope needs to be verified by larger systematic studies.
作为首个系列研究,评估新型前视径向阵列超声内镜用于直肠外结肠癌分期的可行性。
一项对前瞻性录入数据库的回顾性研究。2012年3月至2013年2月,共纳入21例直肠外结肠癌患者(11例男性)(平均年龄64.2岁)。使用新型前视径向阵列超声内镜对直肠外结肠癌进行超声分期。以手术病理作为金标准记录超声T分期和N分期。
到达病变的平均时间和完成操作的平均时间分别为3.5分钟和7.1分钟。13例患者(61.9%)的超声内镜通过了病变,其中10例(76.9%)到达了盲肠。未发现不良事件。病变位于盲肠(n = 2)、升结肠(n = 1)、横结肠(n = 2)、降结肠(n = 2)和乙状结肠(n = 14)。T1期(n = 3)、T2期(n = 4)、T3期(n = 13)和T4期(n = 1)的准确率分别为100%、60.0%、84.6%和100%。结肠癌T分期和N分期的总体准确率分别为81.0%和52.4%。可通过病变(n = 13)和梗阻性病变(n = 8)的准确率分别为61.5%和100%。内镜超声和计算机断层扫描的总体准确率分别为81.0%和68.4%。
超声内镜是直肠外结肠癌可行的分期工具。然而,超声内镜的准确性需要通过更大规模的系统研究来验证。